Inhalator
Latest Glaxo Group Limited Patents:
- Method of producing a recombinant protein
- Antigen binding proteins
- Pharmaceutical formulations comprising 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl) phenol
- Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist
- Compounds
Description
FIG. 1 is a front elevational view of an inhalator showing our new design;
FIG. 2 is a rear elevational view thereof;
FIG. 3 is a top plan view thereof;
FIG. 4 is a bottom plan view thereof;
FIG. 5 is a right side elevational view thereof, the left side elevational view being a mirror image thereof;
FIG. 6 is a right side elevational view thereof shown in a closed position; and,
FIG. 7 is a cross-sectional view thereof, taken along line 7--7 of FIG. 1.
Referenced Cited
Patent History
Patent number: D326517
Type: Grant
Filed: Apr 26, 1989
Date of Patent: May 26, 1992
Assignee: Glaxo Group Limited (London)
Inventors: Kazuya Funai (Tochigi), Norio Eda (Tochigi), Sachio Nakajima (Tokyo)
Primary Examiner: Stella Reid
Law Firm: Darby & Darby
Application Number: 7/344,148
Type: Grant
Filed: Apr 26, 1989
Date of Patent: May 26, 1992
Assignee: Glaxo Group Limited (London)
Inventors: Kazuya Funai (Tochigi), Norio Eda (Tochigi), Sachio Nakajima (Tokyo)
Primary Examiner: Stella Reid
Law Firm: Darby & Darby
Application Number: 7/344,148
Classifications
Current U.S. Class:
Respirator, Vaporizer, Or Inhalation Tube (4) (D24/110)